UpinderSinghMD

Infectious Disease • Stanford, CA

Professor and Division Chief, Infectious Diseases, Stanford University Medical Center

Join to view full profile

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Education & Training

University of Virginia Medical CenterFellowship, Infectious Disease, 1995 - 1998
University of Virginia Medical CenterResidency, Internal Medicine, 1992 - 1995
Ohio State University College of MedicineClass of 1992

Certifications & Licensure

CA State Medical License 2002 - 2025
VA State Medical License 1995 - 2002
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2010

Clinical Trials

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol Start of enrollment: 2021 Apr 23
Completed
Phase 2

Publications & Presentations

PubMed

Identification of two transcription factors that work coordinately to regulate early development in.
Daniela Lozano-Amado, Upinder Singh
Mbio. 2024-12-11
1 citations
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution.
Rebecca E Hamlin, Shaun M Pienkos, Leslie Chan, Mikayla A Stabile, Kassandra Pinedo
Science Translational Medicine. 2024-11-13
1 citations
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, David R Boulware, Matthew W McCarthy
JAMA Network Open. 2024-10-01

Journal Articles

Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce
Wendy Armstrong, Ebbing Lautenbach, Kyle J Popovich, C Buddy Creech, Roger Bedimo, Upinder Singh, Jatin M Vyas, The Journal of Infectious Diseases

Press Mentions

Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers ReportJanuary 6th, 2025
Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 InfectionJune 7th, 2024
Long Covid Patients Abandon Stanford Medicine Study on Infection After Staff Stop Wearing MasksMay 8th, 2023
Join now to see all